The National Institutes of Health (NIH) is funding research on the effects of puberty blockers and cross-sex hormone treatment on youth despite acknowledgment from the grantee that these medical interventions can result in sterility.
A parent or guardian consent form from Children’s Hospital Los Angeles (CHLA), titled “Pubertal Blockers for Minors in Early Adolescence,” states, “If your child starts puberty blockers in the earliest stages of puberty, and then goes on to gender affirming hormones, they will not develop sperm or eggs. This means that they will not be able to have biological children.”
It goes on to read, “This is an important aspect of blocking puberty and progressing to hormones that you should understand prior to moving forward with puberty suppression.” It adds that fertility can be maintained if a child takes puberty blockers but does not undergo cross-sex hormone therapy. Two different studies, however, have found that roughly 98% of children who take puberty blockers go on to take cross-sex hormone therapy.
After the parent/guardian decides to proceed with pubertal blocker medication, the consent form requires the signature of both the parent/guardian and the child (patient).
Dr. Stanley Goldfarb is the director of an advocacy group called Do No Harm, which seeks to “protect healthcare from a radical, divisive, and discriminatory ideology.” He criticized the idea of a minor possibly signing away their ability to reproduce.
Hellbound and Down 
One thought on “NIH Funds Study On Puberty Blockers, Hormones On Youth Despite Risk Of Sterilization”